Arcturus Therapeutics Holdings Inc's Company Valuation
Currency: USD Updated: 2026-06-18
Previous score
7.25
Change
0
The current valuation score of Arcturus Therapeutics Holdings Inc is 7.25, ranking 246 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.66, which is -2536.87% below the recent high of 64.80 and -1348.16% above the recent low of -38.51.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.